Mahoney v. Kijakazi

CourtDistrict Court, N.D. Illinois
DecidedJanuary 10, 2023
Docket1:20-cv-01687
StatusUnknown

This text of Mahoney v. Kijakazi (Mahoney v. Kijakazi) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mahoney v. Kijakazi, (N.D. Ill. 2023).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

KATHLEEN M.,

Plaintiff, No. 20 CV 1687 v.

KILOLO KIJAKAZI, Magistrate Judge McShain ACTING COMMISSIONER OF SOCIAL SECURITY,1

Defendant.

MEMORANDUM OPINION AND ORDER

Plaintiff Kathleen M. brings this action under 42 U.S.C. § 405(g) for judicial review of the Social Security Administration’s (SSA) decision denying her application for benefits. For the following reasons, the Court grants plaintiff’s request to reverse the SSA’s decision and remand this case to the agency [17],2 denies the Commissioner of Social Security’s motion for summary judgment [19], and reverses the SSA’s decision.

Procedural Background

Between late December 2015 and early January 2016, plaintiff filed a Title II application for a period of disability and disability insurance benefits and a Title XVI application for supplemental security income, both alleging an onset date of June 1, 2013. [14-1] 13. Plaintiff’s claims were denied initially and on reconsideration. [Id.]. Plaintiff requested a hearing, which was held by an administrative law judge (ALJ) on March 21, 2018. [Id.]. In a decision dated February 7, 2019, the ALJ ruled that plaintiff was not disabled. [Id.] 37-38. The Appeals Council denied review on January 10, 2020, making the ALJ’s decision the agency’s final decision. [Id.] 1-3. See 20 C.F.R. §§ 404.955, 404.981.

1 In accordance with Fed. R. Civ. P. 25(d), Kilolo Kijakazi, the Acting Commissioner of Social Security is substituted as the defendant in this case in place of the former Commissioner of Social Security, Andrew Saul. 2 Bracketed numbers refer to entries on the district court docket. Referenced page numbers are taken from the CM/ECF header placed at the top of filings, with the exception of citations to the administrative record [14], which refer to the page numbers in the bottom right corner of each page. Plaintiff timely appealed to this Court [1]. The Court has jurisdiction to review the Acting Commissioner’s decision under 42 U.S.C. § 405(g), and the parties have consented to my jurisdiction over the case in accordance with 28 U.S.C. § 636(c). [9].

Summary of Plaintiff’s Medical and Non-Medical Evidence

Plaintiff, 52 years old at the time she applied for disability, was diagnosed with bipolar disorder when she was between 15 and 20 years old. [14-1] 30-31. Plaintiff’s bipolar disorder went untreated for over twenty years. [Id.]. During this period plaintiff “self-medicate[d]” with street drugs. [Id.]. In addition to bipolar disorder, plaintiff was later diagnosed with schizophrenia, major depressive disorder, and generalized anxiety disorder. [Id.] 21. In January 2016, plaintiff was prescribed Risperdal, Carbamazepine, Lexapro, and Klonopin to treat the effects of these disorders. [Id.] 21, 31. Because of plaintiff’s mental impairments plaintiff reported difficulty taking her prescribed medications. [Id.] 25. When plaintiff did not take her medications, her symptoms would worsen causing her to experience episodes of depression, insomnia, and hopelessness. [Id.] 31.

Plaintiff visited the emergency room three times between 2013 and 2015 for “chronic” skin rashes plaintiff herself caused when she picked “until she br[oke] the skin” because she believed “bugs [were] eating her inside out.” [14-5] 448-454, 455- 63, 464-69. During one visit that occurred a few months after the onset of plaintiff’s disability, plaintiff told attending physician, Dr. Christopher Ross, M.D., that she had been off her prescribed antidepressant, Wellbutrin, for two months. [Id.] 465. Dr. Ross observed plaintiff was alert, oriented to person, cooperative, with the appropriate mood and affect. [Id.] 467. Dr. Ross diagnosed plaintiff with depression and delusional parasitosis and plaintiff was given a prescription for Wellbutrin and Risperidone, the latter being an antipsychotic used to treat schizophrenia and bipolar disorder. [Id.]. Plaintiff’s discharge documents do not indicate that plaintiff was diagnosed or treated for substance abuse addiction. [Id.] 448-454, 455-63, 464-69. During her last visit plaintiff explicitly denied drug and alcohol abuse. [Id.] 453.

From October 2015 through November 2016 psychiatrist Paragini Chandarana, performed six psychiatric evaluations of plaintiff. [14-7] 625, 637, 639, 640, 677-78. During the initial psychiatric evaluation Dr. Chandarana noted fluctuating judgment orientation and memory and recorded plaintiff’s delusion that she had bugs all over her body. [Id.] 625. Plaintiff also reported that she is easily angered, has a poor memory, and had stopped taking her prescribed medication for the past two to three months. [Id.]. She diagnosed plaintiff with bipolar disorder and assessed plaintiff’s functioning as fair, with a Global Assessment of Functioning (GAF) score “around 60.” [Id.]. In March 2016, Dr. Chandarana conducted a follow-up psychiatric evaluation where plaintiff reported that since taking her medications she does not see any bugs. [Id.] 637. Plaintiff also reported feeling “very anxious” and that “she does not see friends.” [Id.]. Plaintiff denied drug use. [Id.]. Dr. Chandarana again observed plaintiff had fluctuating judgment, orientation, and memory, and diagnosed plaintiff with schizoaffective disorder bipolar type and in addition to Risperdal, prescribed plaintiff with Depakote and Tegretol to treat plaintiff’s bipolar disorder and schizophrenia. [Id.]. During the second psychiatric follow-up evaluation in May 2016, plaintiff reported running out of medications for two weeks and scratching because she thought she had bugs on her body. [Id.] 639. Dr. Chandarana adjusted plaintiff’s medications, adding Klonopin to plaintiff’s prescription regimen. [Id.]. In June 2016, during plaintiff’s third psychiatric follow-up evaluation, Dr. Chandarana notes indicate that symptoms of plaintiff’s mental disorders worsened. [Id.] 640. She observed that plaintiff had schizoid personality traits and poor interpersonal skills. [Id.]. Plaintiff had fluctuating judgment, orientation, and memory, an affect that was labile and blunted at times, poor insight, and questionable compliance. [Id.]. Dr. Chandarana noted that plaintiff was “[n]ot intoxicated or going through withdrawal.” [Id.]. During plaintiff’s fourth psychiatric follow-up evaluation in October 2016, plaintiff admitted that she stopped taking her medications since July 2016 after her mother died and since experienced psychotic symptoms and delusions of bugs on her skin. [Id.] 677. Dr. Chandarana once again noted plaintiff had fluctuating judgment, orientation, and memory, poor insight, labile affect, and questionable compliance. [Id.]. Plaintiff was “[n]ot intoxicated or going through withdrawal.” [Id.]. At plaintiff’s last psychiatric follow-up with Dr. Chandarana in November 2016, plaintiff stated she was taking her medication and denied drug use. [Id.] 678. Dr. Chandarana observed plaintiff was “well-behaved, cooperative . . . not intoxicated or going through withdrawal.” [Id.]. Plaintiff continued to have fluctuating judgment orientation and memory, poor insight, labile affect, and questionable compliance. [Id.].

Between September 2016 and September 2018, plaintiff had three inpatient hospitalizations for methadone maintenance treatment for her heroin dependence.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Arnett v. Astrue
676 F.3d 586 (Seventh Circuit, 2012)
Berger v. Astrue
516 F.3d 539 (Seventh Circuit, 2008)
Denton v. Astrue
596 F.3d 419 (Seventh Circuit, 2010)
Myles v. Astrue
582 F.3d 672 (Seventh Circuit, 2009)
Mildred Thomas v. Carolyn Colvin
745 F.3d 802 (Seventh Circuit, 2014)
Biestek v. Berryhill
587 U.S. 97 (Supreme Court, 2019)
Jennifer Karr v. Andrew Saul
989 F.3d 508 (Seventh Circuit, 2021)
Walker v. Berryhill
900 F.3d 479 (Seventh Circuit, 2018)
Garcia v. Colvin
741 F.3d 758 (Seventh Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Mahoney v. Kijakazi, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mahoney-v-kijakazi-ilnd-2023.